financetom
Business
financetom
/
Business
/
Waste Management to buy Stericycle in $7.2 bln deal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Waste Management to buy Stericycle in $7.2 bln deal
Jun 3, 2024 4:32 AM

June 3 (Reuters) - Waste Management will buy

medical waste disposal company Stericycle ( SRCL ) in a deal

valued at $7.2 billion, the companies said on Monday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Business travel picks up, bolstering outlook for US airlines
Business travel picks up, bolstering outlook for US airlines
Apr 18, 2024
CHICAGO (Reuters) - U.S. airlines have enjoyed a travel boom for the past three years, but until this past quarter, big-spending corporate travelers had been largely missing. Those customers are now back in full force, boosting profits for carriers in what is normally a weak quarter for results. The U.S. airlines that have so far released results - including Delta,...
Gun makers urge US Supreme Court to hear appeal in Mexico's lawsuit
Gun makers urge US Supreme Court to hear appeal in Mexico's lawsuit
Apr 18, 2024
April 18 (Reuters) - U.S. gun manufacturers on Thursday asked the U.S. Supreme Court hear their challenge to Mexico's $10 billion lawsuit seeking to hold them responsible for facilitating the trafficking of firearms to violent drug cartels across the U.S.-Mexico border. Eight companies including Smith & Wesson Brands ( SWBI ) and Sturm, Ruger & Co ( RGR ) in...
Australia fines Macquarie Bank $6.4 million for not preventing unlawful third-party transactions
Australia fines Macquarie Bank $6.4 million for not preventing unlawful third-party transactions
Apr 18, 2024
(Reuters) - The Federal Court of Australia has fined Macquarie Bank A$10 million ($6.4 million) for its lack of controls to detect and prevent unauthorised fee transactions carried out by third parties on customer accounts, the securities regulator said on Friday. The bank allowed customers to give third parties, such as financial advisers and stockbrokers, different levels of transaction authority,...
FOCUS-China's drugmakers can't sell mRNA shots but haven't quit yet
FOCUS-China's drugmakers can't sell mRNA shots but haven't quit yet
Apr 18, 2024
SHANGHAI/SUZHOU, China, April 19 (Reuters) - China's vaccine developers stuck with unused mRNA COVID shots and idle manufacturing plants are pursuing new targets for the novel messenger RNA technology, but they face a tough path, crimped by a lack of revenue. Three Chinese companies - Walvax Biotechnology, CSPC Pharmaceutical Group ( CHJTF ) and Stemirna Therapeutics - came up with...
Copyright 2023-2026 - www.financetom.com All Rights Reserved